Dermala employs a unique approach to acne treatment that focuses on restoring balance to the body's microbiome, which is the collection of beneficial bacteria residing on the skin and in the gut. Central to their methodology is the patented SE Microbiome Complex®, a proprietary blend of prebiotics and postbiotics designed to combat the acne-causing bacteria, C. acnes, while promoting the growth of beneficial bacteria. This complex is integrated into various topical products, such as the SCANTILY Pad® acne treatment pads, which also contain salicylic acid and Aloe vera. These ingredients work synergistically to reduce inflammation, unclog pores, and promote healing without the harsh side effects commonly associated with traditional acne treatments.

In addition to topical solutions, Dermala offers personalized supplements that support skin health from the inside out. Their acne supplements are formulated with a blend of probiotics, prebiotics, vitamins, and minerals aimed at fostering a balanced gut microbiome, which is crucial for overall skin health. By addressing both the external and internal factors contributing to acne, Dermala's comprehensive system not only targets existing breakouts but also aims to prevent future occurrences, providing a holistic solution to acne management.

United States

DERMALA, Inc. is a pioneering consumer dermatology startup leveraging the power of the human microbiome and cutting-edge data analytics to develop innovative, patented, science-backed, and clinically validated solutions for a range of skin conditions including acne, eczema, and skin health & longevity.

Dermala

Company Details